Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 8
Submit an article Journal homepage
1,712
Views
4
CrossRef citations to date
0
Altmetric
Author's View

Combination of adoptive cell transfer, anti-PD-L1 and anti-LAG-3 antibodies for the treatment of recurrent tumors

Better with more

Stephen R Goding Department of Pathology; University of Maryland School of Medicine; Baltimore, MD USA
,
Kyle A Wilson Department of Microbiology and Immunology; University of Maryland School of Medicine; Baltimore, MD USA
&
Paul Andrew Antony Department of Pathology; University of Maryland School of Medicine; Baltimore, MD USA; Department of Microbiology and Immunology; University of Maryland School of Medicine; Baltimore, MD USA; Tumor Immunology and Immunotherapy Program; University of Maryland Cancer Center; Baltimore, MD USACorrespondence[email protected]
Article: e25050 | Received 15 May 2013, Accepted 15 May 2013, Published online: 20 May 2013

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Nadja Salomon, Fulvia Vascotto, Abderaouf Selmi, Mathias Vormehr, Juliane Quinkhardt, Thomas Bukur, Barbara Schrörs, Martin Löewer, Mustafa Diken, Özlem Türeci, Ugur Sahin & Sebastian Kreiter. (2020) A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice. OncoImmunology 9:1.
Read now
Kyle A Wilson, Stephen R Goding, Harold R Neely, Kristina M Harris & Paul Andrew Antony. (2015) Depletion of B220+NK1.1+ cells enhances the rejection of established melanoma by tumor-specific CD4+ T cells. OncoImmunology 4:8.
Read now

Articles from other publishers (2)

Céline Pisibon, Amira Ouertani, Corine Bertolotto, Robert Ballotti & Yann Cheli. (2021) Immune Checkpoints in Cancers: From Signaling to the Clinic. Cancers 13:18, pages 4573.
Crossref
Stephen R. Goding, Kyle A. Wilson, Carolyn Rosinsky & Paul Andrew Antony. (2018) PD-L1–Independent Mechanisms Control the Resistance of Melanoma to CD4+ T Cell Adoptive Immunotherapy. The Journal of Immunology 200:9, pages 3304-3311.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.